Exelixis is a dedicated biotechnology company focused on developing innovative medicines for patients with cancer. With over 25 years of experience in the biotech sector, Exelixis has established a strong commercial foundation through the success of its lead product, which has enabled the company to reinvigorate its research efforts and expand its team in critical areas such as Drug Discovery, Clinical Development, and Commercial. The company is committed to launching therapies that provide hope to patients and their families, and it actively seeks talented individuals to join its mission of discovering breakthroughs for difficult-to-treat cancers. Exelixis values its employees as its most valuable asset and fosters a collaborative and enthusiastic work environment.